Alnylam Presents New Pre-clinical Data on RNAi Therapeutics at American Heart Association Meeting

-- Alnylam Pharmaceuticals (NASDAQ: ALNY ) announced today that it has presented new pre-clinical data from two RNAi therapeutic programs for cardiovascular disease, including: ALN-PCSsc, an RNAi therapeutic targeting